Industry Discovery & Development Partnership (IDDP) Program
Breakthrough T1D's IDDP Program supports for-profit companies in advancing research and development of innovative therapies, devices, or technologies for type 1 diabetes with commercial potential.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs and proposals accepted year-round)
Funding Amounts: No fixed cap; award size and duration are negotiated per project; company matching funds required.
Summary: Supports for-profit organizations to advance research and development of commercially viable therapies or technologies for type 1 diabetes in alignment with Breakthrough T1D priorities.
Key Information: LOI required; company must match Breakthrough T1D funding; indirect costs not permitted.
Description
The Industry Discovery & Development Partnership (IDDP) Program provides funding and collaborative support to biotechnology, pharmaceutical, device companies, and other for-profit entities for research projects that align with Breakthrough T1D’s priority research areas. The program is designed to accelerate the development and commercialization of therapeutics, devices, and technologies that prevent, treat, or cure type 1 diabetes (T1D).
Breakthrough T1D leverages its expertise and network to foster partnerships, aiming to bring innovative products closer to regulatory approval and market adoption. Projects supported by the IDDP should have clear commercial potential and be positioned to achieve a significant inflection point in their development path.
